FOLLOW US
For Professionals » Research Updates » Obesity

Obesity Research Updates

For Medical Professionals

Comprehensive, Family-Focused Care Needed to Manage Pediatric Obesity
Beyond Genetics, DNA Methylation Identified as New Factor in Obesity
Clinical Reevaluation Needed to Prompt Use of Antiobesity Medications
Obese Patients Achieved Weight Loss with Vagus Nerve Blockade (vBloc)
USPSTF Found Insufficient Evidence to Recommend for or Against Lipid Screening in Asymptomatic Children and Teens
The U.S. Preventive Services Task Force (USPSTF) reviewed evidence for screening asymptomatic children and adolescents for both familial hypercholesterolemia and multifactorial dyslipidemia.
Sorting Out Weight-Loss Programs that Meet Weight Management Guidelines
A wide variety of weight loss programs are in the market place. Patients have to research and decide which weight loss program is right for them.
What Works for Weight Loss Maintenance?
Even as experts continue to wrestle with the optimal methods of weight loss, whether surgical or nonsurgical, they're also focusing on the best ways to maintain the weight loss.
Motivational Interviewing: Key to Inspiring Weight Loss?
Borrowing a technique from addiction specialists, obesity specialists find motivational interviewing helps weight loss patients.
New Clues About Weight Loss Success
Early lapses on a weight loss program predict overall weight loss success, even if weight loss on track, study finds. Acceptance-based treatment beats standard treatment.
Adolescent Bariatric Surgery Reverses Type 2 Diabetes in Nearly All Teens in Recent Study
Three years after undergoing bariatric surgery, adolescents experienced major improvements in their weight, metabolic health, and quality of life, according to findings from the prospective, NIH sponsored Teen-LABS (Longitudinal Assessment of Bariatric Surgery) study.
Prescription Weight Loss Drugs: Patients Want, But Not Long-Term
While speaking at ObesityWeek 2015, Daniel Bessesen, MD proposed a new paradigm, thinking of prescription weight loss medicines as a treatment for a chronic condition—obesity—similar to how physicians treat hypertension, hyperlipidemia and diabetes.
Obesity, Cancer: Evidence Grows Supporting the Link
Overweight and obesity increase the risk of multiple forms of cancer, yet patients remain largely unaware of the association, according to experts speaking at ObesityWeek 2015 in Los Angeles.
Osteoarthritis and Obesity: Anticipated Comorbidities with New Clues to Care
Obesity is a long-known major risk factor for osteoarthritis. Now, scientists are uncovering new information about just how risky excess weight is for joints. They're also discovering other mechanisms besides obesity that may drive risk.
Neuromodulation Shows Promise in the Treatment of Obesity
Neuromodulation targeting the dorsolateral prefrontal cortex (LDLPFC) decreased calorie consumption and increased weight loss in adults with obesity, according to a recent study.
Do Men Need Different Weight Loss Programs?
During ObesityWeek 2015, Melissa Crane, PhD explained men aren't attracted to typical weight loss programs, viewing them as complicated and tailored to women. They want simplified weight loss programs and want to lose weight for health reasons.
Obesity and Chronic Weight Management Medications
Only 2% of the millions of Americans who are eligible for chronic weight management medications are prescribed these agents and only 1% of the millions of Americans who are eligible for bariatric surgery receive this intervention.
Bariatric Surgery Does Not Increase Health Care Costs Among Patients With Obesity and Type 2 Diabetes
This study is the first to examine real-world data on the long-term effect of bariatric surgery on healthcare costs in obese patients according to their diabetes status.
Efficacy of Liraglutide in Lowering Body Weight Shown in Large-Scale Trial
Liraglutide 3.0 mg once daily as an adjunct to a reduced-calorie meal plan and physical activity was associated with clinically meaningful and sustained weight loss in a 56-week, randomized, double-blind trial involving more than 3,700 patients who were overweight or obese.
Nonsurgical ReShape Integrated Dual Balloon System Now Approved to Treat Obesity
A new balloon device to treat obesity without the need for invasive surgery was approved by the U.S. Food and Drug Administration (FDA). The ReShape Integrated Dual Balloon System works by occupying space in the stomach, which limits the space for food intake and triggers feelings of fullness.
AMA Approves Resolution to Improve Obesity Education in Medical Schools
While obesity is an epidemic in the United States, many physicians receive little training on obesity treatment during medical school. Read this article to find out how the American Medical Association and American Society of Bariatric Physicians are working together to resolve this problem.
SHOW MAIN MENU
SHOW SUB MENU